T1	Outcomes 177 202	efficacy and tolerability
T2	Outcomes 881 939	overall response rate (ORR; partial or complete response).
T3	Outcomes 988 991	ORR
T4	Outcomes 1143 1184	prolonged progression-free survival (PFS;
T5	Outcomes 1318 1321	PFS
T6	Outcomes 1488 1514	neutropenia and leukopenia
T7	Outcomes 1654 1690	plasma concentration of doxorubicin.
